thiazolyl blue has been researched along with methyllycaconitine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Fiebre, CM; de Fiebre, NE; Martin, SE | 1 |
1 other study(ies) available for thiazolyl blue and methyllycaconitine
Article | Year |
---|---|
The alpha7 nicotinic acetylcholine receptor-selective antagonist, methyllycaconitine, partially protects against beta-amyloid1-42 toxicity in primary neuron-enriched cultures.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Animals, Newborn; Brain; Cell Death; Cells, Cultured; Dose-Response Relationship, Drug; Drug Interactions; Mice; Neurons; Nicotinic Antagonists; Peptide Fragments; Receptors, Nicotinic; Tetrazolium Salts; Thiazoles | 2004 |